In G/GEJ tumours, CLDN18.2 is reported as the percentage of tumour cells stained with moderate-to-strong membranous stain intensity.1
In G/GEJ tumours, CLDN18.2 is reported as the percentage of tumour cells stained with moderate-to-strong membranous stain intensity.1
Matched H&E and IHC stain of gastric tumour necrosis (10x magnification)
Josef H. Rüschoff, MD
CLDN, claudin; CLDN18.2, claudin 18 isoform 2; G/GEJ, gastric/gastroesophageal junction; H&E, hematoxylin and eosin; IHC, immunohistochemistry
References: 1. Pellino A, Brignola S, Riello E, et al. Association of CLDN18 protein expression with clinicopathological features and prognosis in advanced gastric and gastroesophageal junction adenocarcinomas. J Pers Med. (Epub) 10-26-2021. 2. Rohde C, Yamaguchi R, Mukhina S, et al. Comparison of Claudin 18.2 expression in primary tumors and lymph node metastases in Japanese patients with gastric adenocarcinoma. Jpn J Clin Oncol. 2019;49(9):870-6.